Rabaca, Saturnino J.

HRN: 22-29-77  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/05/2023
CO-AMOXICLAV 625MG (TAB)
11/05/2023
11/11/2023
ORAL
625mg
Bid
PHLEBITIS, CAP
Waiting Final Action 
11/06/2023
CEFTRIAXONE 1G (VIAL)
11/06/2023
11/12/2023
IV
2g
Od
Cap Mr
Waiting Final Action 
11/06/2023
AZITHROMYCIN 500MG TABLET (TAB)
11/06/2023
11/10/2023
ORAL
500mg
OD
Cap Mr
Waiting Final Action 
01/11/2024
MUPIROCIN 2%, 15G (TUBE)
01/11/2024
01/17/2024
TOPICAL
2%
BID
Infected Wound Dorsal Area Left Foot
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: